Bladder cancer

BladderCA · Oncology · 1 drugs · 1 indications

Cancer of the bladder. Includes muscle-invasive and non-muscle-invasive.

Competitive Landscape (1 drugs)

Drug	Company	Mechanism	Modality	Route	Stage
Keytruda	MRK	PD-1 inhibitor	Antibody	IV	APPROVED

Indications (1)

Bladder (1L)

Keytruda APPROVED

Upcoming Catalysts

Sac-TMT + Keytruda - 1L NSCLC - Ph3 - Update (OptiTROP-Lung05)CLINICAL

MRK2026

Keytruda - LOE PreparationCOMPETITIVE

MRKOngoing

Data from Supabase · Updated 2026-03-24